Detalhe da pesquisa
1.
Enhancement of CD147 on M1 macrophages induces differentiation of Th17 cells in the lung interstitial fibrosis.
Biochim Biophys Acta
; 1842(9): 1770-82, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24932516
2.
Combination immunotherapy of glioblastoma with dendritic cell cancer vaccines, anti-PD-1 and poly I:C.
J Pharm Anal
; 13(6): 616-624, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37440907
3.
Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trial.
Signal Transduct Target Ther
; 8(1): 46, 2023 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36717539
4.
CD147-specific chimeric antigen receptor T cells effectively inhibit T cell acute lymphoblastic leukemia.
Cancer Lett
; 542: 215762, 2022 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35659513
5.
Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial.
Signal Transduct Target Ther
; 6(1): 194, 2021 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34001849
6.
CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells.
Signal Transduct Target Ther
; 5(1): 283, 2020 12 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33277466
7.
Targeting CD147 for T to NK Lineage Reprogramming and Tumor Therapy.
EBioMedicine
; 20: 98-108, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28571672